Petros Pharmaceuticals, Inc. (PTPI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -784.27K | -933.54K | -1.13M | -3.01M | -1.66M | 965.4K | -771.25K | -1.66M | -1.13M | -2.26M | -4.05M | -572.07K |
| Operating CF Margin % | - | - | - | - | - | 133.09% | -48.93% | -116.95% | -81.71% | 620.42% | -241.61% | -28.69% |
| Operating CF Growth % | 52.76% | -196.7% | -47.02% | -80.9% | -46.28% | 142.72% | 80.94% | -190.59% | -51.64% | -43.91% | -131.02% | 86.38% |
| Net Income | -987.04K | -336.51K | -922.72K | 4.93M | -1.2M | -9.27M | -2.22M | 384.29K | 382.89K | 318.15K | -4.55M | -2.55M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 667.29K | 768.26K | 754.67K | 753.53K | 934.79K | 860.34K | 826.79K |
| Stock-Based Compensation | 120.32K | 75.14K | 0 | 74.32K | 80.04K | 0 | 0 | 16.83K | 180.38K | 212.74K | 30.84K | 43.32K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -41.02K |
| Other Non-Cash Items | 82.44K | -1.7K | -474.75K | -8.47M | -376.51K | 7.35M | 737.1K | -2.77M | -2.47M | -5.35M | 1.4M | 11.52K |
| Working Capital Changes | 0 | -670.48K | 263.55K | 456.29K | -164.07K | 2.23M | -55.94K | -48.17K | 16.61K | 1.62M | -1.79M | 1.13M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 1.56M | -214.01K | 154.71K | 320.27K | 753.16K | -426.31K | -145.37K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 67.8K | -164.27K | 128.62K | 40.56K | 336.8K | -96.46K | 88.36K |
| Change in Payables | 49.42K | -337.26K | 0 | 417.3K | -211.61K | 727.97K | 0 | -164K | -48.06K | 358.19K | -428.67K | -74.62K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | -5.45K | -19.14K | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -5.45K | -19.14K | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | 0.75% | 1.21% | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | -117.31K | -428.23K | 8.71M | -1.14M | -2.77M | -1.96M | -1.12M | -2.37M | 14.63M | -363.2K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -379.79K | 0 | -374.18K | -368.65K | -363.2K |
| Equity Issued (Net) | 0 | 0 | 0 | -428.23K | 8.71M | -1.14M | 0 | -1.58M | -1.12M | 0 | 0 | 0 |
| Dividends Paid | -232.82K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 232.82K | 0 | -117.31K | 0 | 0 | 0 | -2.77M | 0 | 0 | -2M | 15M | 0 |
| Net Change in Cash | -784.27K | -933.54K | -1.25M | -3.44M | 7.05M | -184.71K | -3.57M | -3.62M | -2.26M | -4.63M | 10.59M | -935.27K |
| Free Cash Flow | -784.27K | -933.54K | -1.13M | -3.01M | -1.66M | 959.96K | -790.38K | -1.66M | -1.13M | -2.26M | -4.05M | -572.07K |
| FCF Margin % | - | - | - | - | - | 132.33% | -50.14% | -116.95% | -81.71% | 620.42% | -241.61% | -28.69% |
| FCF Growth % | 52.76% | -197.25% | -43.46% | -80.9% | -46.28% | 142.48% | 80.47% | -190.59% | -51.64% | -43.91% | -131.02% | 86.38% |
| FCF per Share | -0.02 | -0.00 | -0.03 | -0.12 | -1.43 | 0.01 | -0.08 | -0.23 | -0.24 | -0.95 | -1.91 | -0.27 |
| FCF Conversion (FCF/Net Income) | 0.79x | 2.77x | 1.23x | -0.55x | 0.73x | -0.10x | 0.35x | 2.51x | 0.52x | -7.10x | 0.89x | 0.22x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 114.51K | 0 | 0 | 125.82K | 131.35K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |